What are necrotizing infections?

What Are Necrotizing Infections?

Necrotizing infections are severe, rapidly progressive bacterial infections that cause tissue death (necrosis) in the skin, subcutaneous tissue, fascia, and sometimes muscle, requiring emergency surgical debridement to prevent death. These are life-threatening surgical emergencies with high mortality rates that spread along tissue planes and can lead to septic shock, multi-organ failure, and death within hours to days 1.

Pathophysiology and Microbiology

Necrotizing soft tissue infections (NSTIs) typically involve polymicrobial infections with an average of 5 pathogens per wound, most commonly originating from bowel or genitourinary flora including coliforms and anaerobic bacteria 1. However, monomicrobial infections also occur, particularly with:

• Group A Streptococcus (most common single organism)
• Staphylococcus aureus (including MRSA)
• Clostridial species (gas gangrene)
• Vibrio vulnificus (seawater exposure)
• Aeromonas hydrophila (freshwater exposure)

The infection spreads rapidly along fascial planes, causing thrombosis of blood vessels, tissue ischemia, and progressive necrosis that extends far beyond visible skin changes 2, 3.

Critical Diagnostic Features

The diagnosis is primarily clinical and requires a high index of suspicion, as initial presentation may resemble simple cellulitis 1. The following features distinguish necrotizing infections from superficial soft tissue infections:

Red Flag Clinical Signs 1:

1. Pain disproportionate to physical findings (most important early sign)
2. Hard, wooden feel of subcutaneous tissue extending beyond visible skin involvement
3. Systemic toxicity with altered mental status
4. Edema or tenderness extending beyond the erythema
5. Crepitus (gas in tissues)
6. Bullous lesions
7. Skin necrosis or ecchymoses
8. Failure to respond to initial antibiotic therapy

Common Diagnostic Pitfalls 3:

• Mistaking NSTI for cellulitis or simple wound infection is the most common cause of delayed diagnosis and increased mortality
• Absence of tissue gas does not exclude NSTI—gas is not universally present
• Subtle skin findings in immunocompromised patients can mask severe deep tissue involvement 4
• CT or MRI may delay definitive treatment—clinical judgment trumps imaging 1

Definitive Diagnosis

The gold standard is direct surgical visualization of the fascial planes 1. At operation, the fascia appears:

• Swollen and dull gray
• Stringy areas of necrosis
• Thin brownish exudate (not true pus)
• Easy dissection along tissue planes with a gloved finger or blunt instrument
• Extensive undermining of surrounding tissues

Treatment Algorithm

1. Immediate Surgical Debridement (Primary Treatment)

Surgery is the definitive treatment and must not be delayed 1. Indications for emergency surgery include:

• Any clinical features listed above
• Failure of apparent cellulitis to respond to antibiotics
• Profound toxicity, fever, hypotension, or advancing infection during antibiotic therapy
• Skin necrosis with easy fascial dissection
• Gas in soft tissues

Patients require return to the operating room every 24-36 hours until no further debridement is needed 1. Incision and drainage is inadequate—excisional debridement is required 3.

2. Empiric Antibiotic Therapy

Broad-spectrum coverage for aerobes (including MRSA) and anaerobes is mandatory 1:

Recommended regimens:

• Vancomycin, linezolid, or daptomycin PLUS one of:
  • Piperacillin-tazobactam
  • Carbapenem (imipenem, meropenem, or ertapenem)
  • Ceftriaxone plus metronidazole
  • Fluoroquinolone plus metronidazole

3. Targeted Therapy for Group A Streptococcus

For confirmed or suspected streptococcal necrotizing fasciitis with toxic shock syndrome, use clindamycin PLUS penicillin 1.

Rationale: Clindamycin suppresses toxin production and was superior to penicillin in animal models and observational studies. Penicillin is added due to potential clindamycin resistance (though <5% in the US) 1. Emerging data suggest linezolid may be a safe alternative given rising clindamycin resistance 5.

4. Duration of Antibiotics

Continue antibiotics until:

• No further debridement is necessary
• Clinical improvement occurs
• Fever absent for 48-72 hours 1

Emerging evidence supports shorter courses following definitive surgical source control, even with concurrent bacteremia 5.

5. Supportive Care

• Aggressive fluid resuscitation—wounds discharge copious tissue fluid 1
• Intensive care unit monitoring for septic shock and organ failure
• IVIG for streptococcal toxic shock syndrome has unestablished efficacy 1

Key Clinical Pearls

• Mortality remains high (15-30%) despite modern treatment 6, 3
• Delay in diagnosis or inadequate debridement are the two most common causes of death 3
• Approximately 500-1,500 cases occur annually in the United States 6
• Immunocompromised patients may have atypical presentations with minimal inflammatory response 4
• Any injection site with disproportionate pain warrants immediate evaluation, especially in immunosuppressed patients 4